Pharmaceuticals: Customs dispute with Trump - pharmaceutical industry expects lower sales
Threats, uncertainty, hardly any predictability: The dispute over pharmaceutical tariffs with Donald Trump is leaving its mark on the pharmaceutical industry. After a strong previous year, things are now going downhill.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.